{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:58:16Z","timestamp":1790776696055,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017530","name":"Fresenius Kabi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Early data suggest use of a mixed lipid emulsion (LE) with a soybean oil reduction strategy in parenteral nutrition (PN) may improve clinical outcomes. Duke University Hospital made a full switch to a Soybean oil\/MCT\/Olive\/Fish Oil lipid (4-OLE) from pure soybean oil-based LE (<jats:italic>Intralipid<\/jats:italic>, Baxter Inc) in May 2017. Since 4-OLE has limited evidence related to its effects on clinical outcome parameters in US hospitals, evidence for clinical benefits of switching to 4-OLE is needed. Therefore, we examined the clinical utility of a hospital-wide switch to 4-OLE and its effect on patient outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a single-center retrospective cohort study among adult patients (&gt;\u200918\u00a0years) requiring PN from 2016 to 2019. Our primary exposure was treatment period (1-year pre-4-OLE switch versus 2-year post). We used multivariable regression models to examine our primary outcomes, the association of treatment period with hospital length of stay (LOS), and secondary outcomes liver function, infections, and ICU LOS. Analyses were stratified into critically ill and entire adult cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 1200 adults hospitalized patients. 28% of PN patients (<jats:italic>n<\/jats:italic>\u2009=\u2009341) were treated pre-4-OLE switch and 72% post-4-OLE (<jats:italic>n<\/jats:italic>\u2009=\u2009859). In the adult cohort, 4-OLE was associated with shorter hospital LOS (IRR 0.97, 95% CI 0.95\u20130.99, <jats:italic>p<\/jats:italic>\u2009=\u20090.039). The ICU cohort included 447 subjects, of which 25% (<jats:italic>n<\/jats:italic>\u2009=\u2009110) were treated pre-4-OLE switch and 75% (<jats:italic>n<\/jats:italic>\u2009=\u2009337) were post-switch. ICU patients receiving 4-OLE were associated with shorter hospital LOS (IRR 0.91, 95% CI 0.87\u20130.93, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), as well as a shorter ICU LOS (IRR 0.90, 95% CI 0.82\u20130.99, <jats:italic>p<\/jats:italic>\u2009=\u20090.036). 4-OLE ICU patients also had a significantly lower delta total bilirubin (\u2212\u00a01.6, 95% CI \u2212\u00a02.8 to \u2212\u00a00.2, <jats:italic>p<\/jats:italic>\u2009=\u20090.021) and reduced urinary tract infection (UTI) rates (OR 0.50, 95% CI 0.26\u20130.96, <jats:italic>p<\/jats:italic>\u2009=\u20090.038). There were no associations in AST, ALT, or total bilirubin in ICU and all adult patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>4-OLE was successfully implemented and reduced soybean oil LE exposure in a large academic hospital setting. The introduction of 4-OLE was associated with reduced LOS, UTI rates, and mitigated hepatic dysfunction in critically ill patients. Overall, these findings prove a switch to a soybean oil-LE sparing strategy using 4-OLE is feasible and safe and is associated with improved clinical outcomes in adult PN patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-022-04194-8","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T10:03:13Z","timestamp":1666087393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Hospital change to mixed lipid emulsion from soybean oil-based lipid emulsion for parenteral nutrition in hospitalized and critically ill adults improves outcomes: a pre\u2013post-comparative study"],"prefix":"10.1186","volume":"26","author":[{"given":"Krista L.","family":"Haines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Ohnuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obanor","family":"Osamudiamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Raghunathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Wischmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"issue":"5","key":"4194_CR1","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jand.2012.03.012","volume":"112","author":"JV White","year":"2012","unstructured":"White JV, Guenter P, Jensen G, Malone A, Schofield M, Group AMW, Force AMT, of Directors AB. Consensus statement of the academy of nutrition and dietetics\/American Society for parenteral and enteral nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). J Acad Nutr Diet. 2012;112(5):730\u20138.","journal-title":"J Acad Nutr Diet"},{"issue":"2","key":"4194_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.15171\/apb.2019.037","volume":"9","author":"F Osooli","year":"2019","unstructured":"Osooli F, Abbas S, Farsaei S, Adibi P. Identifying critically ill patients at risk of malnutrition and underfeeding: a prospective study at an academic hospital. Adv Pharm Bull. 2019;9(2):314.","journal-title":"Adv Pharm Bull"},{"issue":"6","key":"4194_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.7861\/clinmedicine.10-6-624","volume":"10","author":"J Saunders","year":"2010","unstructured":"Saunders J, Smith T. Malnutrition: causes and consequences. Clin Med. 2010;10(6):624.","journal-title":"Clin Med"},{"issue":"6","key":"4194_CR4","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1177\/0148607109344724","volume":"33","author":"GL Jensen","year":"2009","unstructured":"Jensen GL, Bistrian B, Roubenoff R, Heimburger DC. Malnutrition syndromes: a conundrum vs continuum. J Parenter Enter Nutr. 2009;33(6):710\u20136.","journal-title":"J Parenter Enter Nutr"},{"issue":"12","key":"4194_CR5","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1097\/CCM.0000000000001306","volume":"43","author":"KM Mogensen","year":"2015","unstructured":"Mogensen KM, Robinson MK, Casey JD, Gunasekera NS, Moromizato T, Rawn JD, Christopher KB. Nutritional status and mortality in the critically ill. Crit Care Med. 2015;43(12):2605\u201315.","journal-title":"Crit Care Med"},{"issue":"2","key":"4194_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/0148607115621863","volume":"40","author":"SA McClave","year":"2016","unstructured":"McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, McCarthy MS, Davanos E, Rice TW, Cresci GA. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN). JPEN J Parenter Enteral Nutr. 2016;40(2):159\u2013211.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"4","key":"4194_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1017\/S0029665110000157","volume":"69","author":"PC Calder","year":"2010","unstructured":"Calder PC. Rationale and use of n-3 fatty acids in artificial nutrition. Proc Nutr Soc. 2010;69(4):565\u201373.","journal-title":"Proc Nutr Soc"},{"issue":"5","key":"4194_CR8","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/ajcn\/85.5.1171","volume":"85","author":"GJ Wanten","year":"2007","unstructured":"Wanten GJ, Calder PC. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr. 2007;85(5):1171\u201384.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"4194_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/15563650.2016.1151528","volume":"54","author":"BD Hayes","year":"2016","unstructured":"Hayes BD, Gosselin S, Calello DP, Nacca N, Rollins CJ, Abourbih D, Morris M, Nesbitt-Miller A, Morais JA, Lavergne V. Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration. Clin Toxicol. 2016;54(5):365\u2013404.","journal-title":"Clin Toxicol"},{"issue":"3","key":"4194_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0899-9007(01)00784-5","volume":"18","author":"K Furukawa","year":"2002","unstructured":"Furukawa K, Yamamori H, Takagi K, Hayashi N, Suzuki R, Nakajima N, Tashiro T. Influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients. Nutrition. 2002;18(3):235\u201340.","journal-title":"Nutrition"},{"issue":"4","key":"4194_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1177\/0148607184008004381","volume":"8","author":"I Fraser","year":"1984","unstructured":"Fraser I, Neoptolemos J, Darby H, Bell P. The effects of intralipid and heparin on human monocyte and lymphocyte function. J Parenter Enter Nutr. 1984;8(4):381\u20134.","journal-title":"J Parenter Enter Nutr"},{"issue":"5","key":"4194_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0271-5317(89)80176-9","volume":"9","author":"RC Chu","year":"1989","unstructured":"Chu RC, Barkowski SM. The effects of rate and dose of intralipid infusion on bacterial clearance and granulocytic activity of the rat. Nutr Res. 1989;9(5):513\u201322.","journal-title":"Nutr Res"},{"issue":"8199","key":"4194_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(80)90171-3","volume":"316","author":"G Fischer","year":"1980","unstructured":"Fischer G, Wilson S, Hunter K, Mease A. Diminished bacterial defences with intralipid. The Lancet. 1980;316(8199):819\u201320.","journal-title":"The Lancet"},{"issue":"2","key":"4194_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0899-9007(96)00386-3","volume":"13","author":"DL Waitzberg","year":"1997","unstructured":"Waitzberg DL, Bellinati-Pires R, Salgado MM, Hypolito IP, Colleto GM, Yagi O, Yamamuro EM, Gama-Rodrigues J, Pinotti HW. Effect of total parenteral nutrition with different lipid emulsions on human monocyte and neutrophil functions. Nutrition. 1997;13(2):128\u201332.","journal-title":"Nutrition"},{"issue":"5","key":"4194_CR15","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/MPG.0000000000001121","volume":"62","author":"I Hojsak","year":"2016","unstructured":"Hojsak I, Colomb V, Braegger C, Bronsky J, Campoy C, Domell\u00f6f M, Embleton N, Fidler Mis N, Hulst JM, Indrio F, et al. ESPGHAN committee on nutrition position paper. Intravenous lipid emulsions and risk of hepatotoxicity in infants and children: a systematic review and meta-analysis. J Pediatr Gastroenterol Nutr. 2016;62(5):776\u201392.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"4194_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/0884533612439896","volume":"27","author":"VW Vanek","year":"2012","unstructured":"Vanek VW, Seidner DL, Allen P, Bistrian B, Collier S, Gura K, Miles JM, Valentine CJ, Kochevar M. Novel nutrient task force IFEW: ASPEN position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2012;27(2):150\u201392.","journal-title":"Nutr Clin Pract"},{"key":"4194_CR17","unstructured":"Heyland D, Benst\u00f6m C: Nutrition support in mechanically ventilated, critically ill adult patients\u2013study protocol for systematic reviews and meta-analyses. From website: www.criticalcarenutrition.com, URL: https:\/\/www.criticalcarenutrition.com\/docs\/systematic_reviews_2018\/Systematic%20Review%20Protocol%20CCN_Dec%202018.pdf. Accessed 15 Oct 2022."},{"issue":"1","key":"4194_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1054\/clnu.2002.0592","volume":"22","author":"M K\u00f6ller","year":"2003","unstructured":"K\u00f6ller M, Senkal M, Kemen M, K\u00f6nig W, Zumtobel V, Muhr G. Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clin Nutr. 2003;22(1):59\u201364.","journal-title":"Clin Nutr"},{"issue":"7","key":"4194_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.12998\/wjcc.v4.i7.155","volume":"4","author":"K Moro","year":"2016","unstructured":"Moro K, Nagahashi M, Ramanathan R, Takabe K, Wakai T. Resolvins and omega three polyunsaturated fatty acids: clinical implications in inflammatory diseases and cancer. World J Clin Cases. 2016;4(7):155.","journal-title":"World J Clin Cases"},{"issue":"1","key":"4194_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13054-022-03896-3","volume":"26","author":"Q Notz","year":"2022","unstructured":"Notz Q, Lee ZY, Menger J, Elke G, Hill A, Kranke P, Roeder D, Lotz C, Meybohm P, Heyland DK, et al. Omega-6 sparing effects of parenteral lipid emulsions-an updated systematic review and meta-analysis on clinical outcomes in critically ill patients. Crit Care. 2022;26(1):23.","journal-title":"Crit Care"},{"issue":"1","key":"4194_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/0148607113486006","volume":"38","author":"W Manzanares","year":"2014","unstructured":"Manzanares W, Dhaliwal R, Jurewitsch B, Stapleton RD, Jeejeebhoy KN, Heyland DK. Parenteral fish oil lipid emulsions in the critically ill: a systematic review and meta-analysis. J Parenter Enter Nutr. 2014;38(1):20\u20138.","journal-title":"J Parenter Enter Nutr"},{"issue":"3","key":"4194_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000091683","volume":"50","author":"N Mertes","year":"2006","unstructured":"Mertes N, Grimm H, F\u00fcrst P, Stehle P. Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid) in surgical patients: a randomized, double-blind, multicenter study. Ann Nutr Metab. 2006;50(3):253\u20139.","journal-title":"Ann Nutr Metab"},{"issue":"12","key":"4194_CR23","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/nure.12053","volume":"71","author":"H Tian","year":"2013","unstructured":"Tian H, Yao X, Zeng R, Sun R, Tian H, Shi C, Li L, Tian J, Yang K. Safety and efficacy of a new parenteral lipid emulsion (Smof) for surgical patients: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2013;71(12):815\u201321.","journal-title":"Nutr Rev"},{"key":"4194_CR24","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1002\/jpen.1733","volume":"44","author":"K Mayer","year":"2020","unstructured":"Mayer K, Klek S, Garc\u00eda-de-Lorenzo A, Rosenthal MD, Li A, Evans DC, Muscaritoli M, Martindale RG. Lipid use in hospitalized adults requiring parenteral nutrition. J Parenter Enter Nutr. 2020;44:S28\u201338.","journal-title":"J Parenter Enter Nutr"},{"key":"4194_CR25","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1002\/jpen.1746","volume":"44","author":"RG Martindale","year":"2020","unstructured":"Martindale RG, Berlana D, Boullata JI, Cai W, Calder PC, Deshpande GH, Evans D, Garcia-de-Lorenzo A, Goulet OJ, Li A. Summary of proceedings and expert consensus statements from the international summit \u201cLipids in Parenteral Nutrition.\u201d J Parenter Enter Nutr. 2020;44:S7\u201320.","journal-title":"J Parenter Enter Nutr"},{"key":"4194_CR26","first-page":"6301293.","volume":"2018","author":"AA Leguina-Ruzzi","year":"2018","unstructured":"Leguina-Ruzzi AA, Ortiz R. Current evidence for the use of smoflipid\u00ae emulsion in critical care patients for parenteral nutrition. Crit Care Res Pract. 2018;2018:6301293.","journal-title":"Crit Care Res Pract"},{"issue":"1","key":"4194_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jpen.1672","volume":"44","author":"L Pradelli","year":"2020","unstructured":"Pradelli L, Mayer K, Klek S, Omar Alsaleh AJ, Clark RA, Rosenthal MD, Heller AR, Muscaritoli M. \u03c9-3 fatty-acid enriched parenteral nutrition in hospitalized patients: systematic review with meta-analysis and trial sequential analysis. J Parenter Enter Nutr. 2020;44(1):44\u201357.","journal-title":"J Parenter Enter Nutr"},{"issue":"6","key":"4194_CR28","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","volume":"47","author":"C van Walraven","year":"2009","unstructured":"van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626\u201333.","journal-title":"Med Care"},{"issue":"1","key":"4194_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1023\/A:1021530924455","volume":"3","author":"K Carey","year":"2002","unstructured":"Carey K. Hospital length of stay and cost: a multilevel modeling analysis. Health Serv Outcomes Res Method. 2002;3(1):41\u201356.","journal-title":"Health Serv Outcomes Res Method"},{"issue":"2","key":"4194_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cld.2012.03.012","volume":"16","author":"A Siddique","year":"2012","unstructured":"Siddique A, Kowdley KV. Approach to a patient with elevated serum alkaline phosphatase. Clin Liver Dis. 2012;16(2):199\u2013229.","journal-title":"Clin Liver Dis"},{"key":"4194_CR31","unstructured":"Hartl WH, Jauch K-W, Parhofer K, Rittler P. Medicine WGfDtGfPNotGAfN: Complications and monitoring\u2013guidelines on parenteral nutrition, Chapter 11. GMS Ger Med Sci 2009;7:Doc17."},{"issue":"6","key":"4194_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0261-5614(03)00082-7","volume":"22","author":"J Llop","year":"2003","unstructured":"Llop J, Sabin P, Garau M, Burgos R, P\u00e9rez M, Masso J, Cardona D, Segura JS, Garriga R, Redondo S. The importance of clinical factors in parenteral nutrition-associated hypertriglyceridemia. Clin Nutr. 2003;22(6):577\u201383.","journal-title":"Clin Nutr"},{"issue":"8","key":"4194_CR33","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/s41372-019-0425-7","volume":"39","author":"R Torgalkar","year":"2019","unstructured":"Torgalkar R, Dave S, Shah J, Ostad N, Kotsopoulos K, Unger S, Shah PS. Multi-component lipid emulsion vs soy-based lipid emulsion for very low birth weight preterm neonates: a pre-post comparative study. J Perinatol. 2019;39(8):1118\u201324.","journal-title":"J Perinatol"},{"issue":"5","key":"4194_CR34","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ncp.10496","volume":"35","author":"JM Mirtallo","year":"2020","unstructured":"Mirtallo JM, Ayers P, Boullata J, Gura KM, Plogsted S, Anderson CR, Worthington P, Seres DS, Nicolai E, Alsharhan M, et al. ASPEN lipid injectable emulsion safety recommendations, part 1: background and adult considerations. Nutr Clin Pract. 2020;35(5):769\u201382.","journal-title":"Nutr Clin Pract"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-04194-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04194-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T10:03:20Z","timestamp":1666087400000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-04194-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4194"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-04194-8","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,18]]},"assertion":[{"value":"18 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed by the Duke Institutional and Ethics Review Board and was granted approval (Approval No.: Pro00102602).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable; all authors have seen and approved the final version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Wischmeyer reports receiving investigator-initiated grant funding related to this work from National Institutes of Health, Department of Defense, Canadian Institutes of Health Research, Abbott, Baxter, and Fresenius. Dr. Wischmeyer has served as a consultant to Abbott, Fresenius, Baxter, Cardinal Health, and Nutricia, for research related to this work. Dr. Wischmeyer has received unrestricted gift donation for nutrition research from Musclesound and DSM. Dr. Wischmeyer has received honoraria or travel expenses for CME lectures on improving nutrition care from Abbott, Baxter, Fresenius, Danone-Nutricia, DSM, and Nestle. Dr. Haines has received investigator-initiated grant funding from American Society for Parenteral and Enteral Nutrition, National Institutes of Health, and Abbott. Dr. Haines has received honoraria for CME lectures from Fresenius.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}